We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.77B
AUM Growth
-$242M
Cap. Flow
-$349M
Cap. Flow %
-12.6%
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77

Sector Composition

Rank Sector Weight
1 Healthcare 22.04%
2 Technology 19.82%
3 Consumer Discretionary 16.91%
4 Industrials 13.94%
5 Financials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLL icon
76
Collegium Pharmaceutical
COLL
$1.17B
$17.8M 0.64%
748,938
-86,704
-10% -$2.06M
ALGM icon
77
Allegro MicroSystems
ALGM
$8.66B
$17.6M 0.63%
693,418
-89,060
-11% -$2.55M
MMSI icon
78
Merit Medical Systems
MMSI
$4.41B
$17.1M 0.62%
285,361
+156,584
+122% +$8.97M
TPTX
79
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$17.1M 0.62%
180,508
-176,530
-49% -$21M
FORM icon
80
FormFactor
FORM
$8.23B
$16.9M 0.61%
373,533
+119,015
+47% +$5.41M
COHR icon
81
Coherent
COHR
$54.3B
$16.7M 0.6%
244,444
-170,659
-41% -$14M
CNK icon
82
Cinemark Holdings
CNK
$3.55B
$16.6M 0.6%
815,655
+759,885
+1,363% +$16M
CVET
83
DELISTED
Covetrus, Inc. Common Stock
CVET
$16M 0.58%
534,081
+11,506
+2% +$392K
ORIC icon
84
Oric Pharmaceuticals
ORIC
$1.11B
$15.1M 0.54%
615,511
+93,209
+18% +$2.95M
WOOF icon
85
Petco
WOOF
$760M
$14.3M 0.52%
+645,822
New +$15.4M
LIND icon
86
Lindblad Expeditions
LIND
$1.82B
$13.8M 0.5%
+728,872
New +$13.3M
RPAY icon
87
Repay Holdings
RPAY
$321M
$13.6M 0.49%
580,683
+41,630
+8% +$1.01M
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$13.4M 0.48%
524,932
-59,410
-10% -$1.52M
PLCE icon
89
Children's Place
PLCE
$65.8M
$13.3M 0.48%
191,494
-85,255
-31% -$5.97M
SMCI icon
90
Super Micro Computer
SMCI
$15.6B
$13.1M 0.47%
3,350,770
+426,500
+15% +$1.45M
DCPH
91
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12.8M 0.46%
285,846
-39,280
-12% -$1.83M
JAMF
92
DELISTED
Jamf
JAMF
$12.7M 0.46%
359,143
+56,105
+19% +$2.05M
TGTX icon
93
TG Therapeutics
TGTX
$8.4B
$12.1M 0.44%
+251,857
New +$12.1M
STMP
94
DELISTED
Stamps.com, Inc.
STMP
$12M 0.43%
59,903
-43,625
-42% -$9.3M
TECX
95
Tectonic Therapeutic
TECX
$615M
$11.6M 0.42%
76,435
-7,666
-9% -$1.25M
SEER icon
96
Seer Inc
SEER
$119M
$11.3M 0.41%
226,192
+201,942
+833% +$11.8M
SPNE
97
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11.1M 0.4%
636,254
+168,246
+36% +$3.02M
CCXI
98
DELISTED
ChemoCentryx, Inc.
CCXI
$11M 0.4%
214,672
-249,289
-54% -$15M
PING
99
DELISTED
Ping Identity Holding Corp.
PING
$11M 0.4%
501,368
-59,290
-11% -$1.67M
RHP icon
100
Ryman Hospitality Properties
RHP
$7.99B
$10.8M 0.39%
+139,035
New +$10.3M

Similar funds

Emerald Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.

  • Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
  • Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
  • Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
  • Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
  • Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
  • Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.

Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.